CD20 is a commonly expressed mature B-cell antigen and is also expressed on a large proportion of B-cell lymphomas, whereas CD22 is an inhibitory co-receptor expressed on a range of mature B-cells, immature B-cells and B-cell lymphomas. This evidence concerns the gene CD22 and B-cell non-Hodgkin lymphoma.